Related by context. All words. (Click for frequent words.) 69 tipranavir 69 LPV r 69 lopinavir r 69 tipranavir r 68 APTIVUS R 67 enfuvirtide 67 APTIVUS r 67 TPV r 67 darunavir r 67 CIMZIA TM 67 carboplatin paclitaxel 66 decitabine 66 Peg IFN 66 BEACOPP 66 clodronate 66 Elitek 66 comparator arm 66 TMC# r 66 Aptivus ® 66 oral allopurinol 66 Fludara 66 pegylated interferon alfa 2b 66 placebo dexamethasone 65 experienced virologic failure 65 Flu Cy 65 pegylated liposomal doxorubicin 65 AZT zidovudine Retrovir 65 DOXIL 65 daunorubicin 65 unboosted 65 glatiramer acetate 65 LEXIVA r 65 ritonavir boosted 65 topotecan 65 insulin detemir 64 oblimersen 64 boosted protease inhibitor 64 interferon ribavirin 64 doxorubicin docetaxel 64 chlorambucil 64 IFN α 64 piperacillin tazobactam 64 mg kg dose 64 darunavir 64 isoproterenol 64 FOLFIRI 64 raltegravir 64 virologic response 64 low dose ritonavir 64 Darunavir 64 fosamprenavir 64 Copegus ribavirin 64 CANCIDAS 64 PREZISTA r 64 PegIFN RBV 63 tipranavir ritonavir 63 adalimumab Humira 63 Doxil ® 63 ritonavir boosted lopinavir 63 mRCC 63 NXL# 63 azacitidine 63 HBeAg seroconversion 63 darunavir ritonavir 63 adalimumab 63 atazanavir ritonavir 63 PREZISTA rtv 63 pegylated interferon alpha 63 Erlotinib 63 protease inhibitor PI 63 oral diclofenac 63 iodixanol 63 achieved sustained virological 63 peginterferon alfa 2b 63 neostigmine 63 INTELENCE 63 viral kinetics 62 5-FU/LV 62 PegIFN 62 low dose cytarabine 62 docetaxel prednisone 62 REYATAZ ® 62 APTIVUS 62 VIRAMUNE 62 estramustine 62 PREZISTA ritonavir 62 CIMZIA ™ 62 #mg BID [003] 62 FluCAM 62 sustained virological response 62 antiandrogen 62 boosted atazanavir 62 indinavir 62 mitomycin 62 ribavirin RBV 62 Pemetrexed 62 levosimendan 62 cisplatin vinorelbine 62 Durezol 62 mapatumumab 62 nadolol 62 HIV RNA 62 Gefitinib 62 abacavir lamivudine 62 trabectedin 62 peginterferon 62 FOLFOX4 62 Taxotere ® 62 micafungin 62 p = NS 62 lopinavir ritonavir 62 docetaxel Taxotere 62 mitoxantrone 62 mycophenolate mofetil 62 Irinotecan 61 ABC/3TC 61 goserelin 61 DAPT 61 trastuzumab Herceptin ® 61 peginterferon alfa 2a 61 degarelix 61 tacrolimus ointment 61 divalproex sodium 61 virologic 61 NRTIs 61 gemcitabine Gemzar 61 pyrazinamide 61 azacytidine 61 rFSH 61 REYATAZ R 61 atazanavir sulfate 61 Pegylated Interferon 61 genotypic resistance 61 steroid dexamethasone 61 chemotherapy docetaxel 61 PEG IFN 61 IFN alfa 61 mcg doses 61 PEG interferon 61 Gemcitabine 61 cinacalcet 61 interferon alfa 61 virologic failure 61 octreotide LAR 61 vicriviroc 61 atorvastatin #mg 61 CR nPR 61 virologic failures 61 NRTI 61 TDF FTC 61 certolizumab 61 stavudine d4T 61 nelfinavir 61 tenofovir emtricitabine 61 etravirine 61 XELOX 61 μg dose 61 mutated KRAS 61 active comparator 61 cabazitaxel 61 subcutaneously administered 61 glargine 61 Kivexa 60 5FU 60 paclitaxel Taxol 60 urate lowering therapy 60 Pred Forte 60 NATRECOR R 60 docetaxel chemotherapy 60 LMWH 60 ceftazidime 60 fluorouracil 60 nicardipine 60 mcg dose 60 GPIIb IIIa inhibitors 60 CsA 60 flutamide 60 CYPHER Stent 60 overlapping toxicities 60 anti leukemic 60 azathioprine 60 Pegasys peginterferon alfa 2a 60 mg QD 60 NNRTI resistance 60 efavirenz EFV 60 pegylated interferon alfa 60 virological suppression 60 melphalan prednisone 60 TACE 60 complete cytogenetic response 60 virological failure 60 dose cytarabine 60 sustained virologic response 60 #mg QD [001] 60 gemcitabine cisplatin 60 paricalcitol 60 Epirubicin 60 alpha 2a 60 bortezomib 60 fluticasone salmeterol 60 Fulvestrant 60 salmeterol fluticasone 60 dacarbazine 60 LHRH agonist 60 heavily pretreated patients 60 Cytoxan 60 fibrinolytic 60 zoledronate 60 bicalutamide 60 systemic bioavailability 60 alfa 2a 60 amprenavir 60 plus dexamethasone 60 caspofungin 60 PASI scores 60 infusional 5-FU/LV 60 -#.# log# 60 noninferior 60 Interferon alfa 60 CD4 + cell 60 imipenem 60 tirofiban 60 rizatriptan 60 nitazoxanide 60 Aloxi injection 60 amoxicillin clavulanate 60 relapsed MM 60 canakinumab 60 rhGH 60 DMARDs 60 remifentanil 60 IFN beta 60 pomalidomide 60 β blockers 60 dalteparin 60 lopinavir r arm 60 irbesartan 60 HBeAg 60 amphotericin B 60 atazanavir Reyataz 60 ramipril 60 pCR 59 Fluconazole 59 diuretic chlorthalidone 59 mcg BID 59 gliclazide 59 receiving VICTRELIS 59 leukocyte count 59 ibandronate 59 ritonavir boosted atazanavir 59 bendamustine 59 ISENTRESS 59 HBeAg negative patients 59 d4T stavudine Zerit 59 idarubicin 59 sunitinib 59 #mg dose [003] 59 gemifloxacin 59 mcg QD 59 prednisone prednisolone 59 dose cyclophosphamide 59 tenofovir FTC 59 #mg doses [002] 59 eplerenone 59 fondaparinux 59 etoposide 59 mg BID 59 plasma renin activity 59 tocilizumab 59 Alkeran 59 lispro 59 antithrombotics 59 cidofovir 59 corticosteroid dose 59 antidiabetic 59 vinorelbine 59 unfractionated heparin UFH 59 tumor necrosis 59 Taxol paclitaxel 59 unfractionated heparin 59 mg ustekinumab 59 virologic breakthrough 59 hematologic toxicity 59 SVR# 59 liposomal doxorubicin 59 inhibitor RG# 59 interferon alfa 2a 59 argatroban 59 pharmacokinetic interactions 59 clevidipine 59 rilpivirine 59 lenalidomide dexamethasone 59 HCV replicon 59 ULORIC 59 adefovir 59 gemcitabine carboplatin 59 idraparinux 59 NNRTI 59 splenectomized patients 59 SCIg 59 plasma uric acid 59 sunitinib malate 59 imatinib 59 antithrombotic 59 Viramune ® 59 posaconazole 59 locoregional disease 59 chemotherapeutic regimen 59 mcg Albuferon 59 abciximab 59 microtubule targeting 59 neutrophil counts 59 dosage regimens 59 dose dexamethasone 59 Capecitabine 59 seliciclib 59 peak plasma concentrations 59 salmeterol fluticasone propionate 59 platelet inhibitor 59 Pioglitazone 59 dexmedetomidine 59 vandetanib 59 IRESSA 59 nucleoside 59 timolol 59 thalidomide Thalomid 59 doxorubicin cyclophosphamide 59 adjuvant tamoxifen 59 desvenlafaxine succinate 59 lamivudine 59 Velcade bortezomib 59 pegIFN 59 oxycodone CR 59 peginterferon alfa 2a #KD 59 dose atorvastatin 59 CHOP chemotherapy 59 Blinatumomab 59 Neulasta ® 59 tigecycline 59 HBV DNA 59 pamidronate 59 primary patency 59 RGT arm 59 nilotinib 59 Lenalidomide 59 cART 59 sevelamer 59 HbA 1c levels 59 eptifibatide 59 voriconazole 59 MGd 59 prospectively defined 58 neoadjuvant chemotherapy 58 uric acid lowering 58 KRAS mutations occur 58 cisplatin chemotherapy 58 viral suppression 58 talabostat 58 celgosivir 58 HPV-#/# 58 sirolimus eluting stent 58 #mg/m# [001] 58 CA4P 58 bacillus Calmette Guerin 58 reteplase 58 DFMO 58 metastatic renal cell carcinoma 58 Trastuzumab 58 ZYVOX 58 FIRMAGON 58 viral titers 58 systemic absorption 58 FOLFIRINOX 58 mg/m2 dose 58 Hycamtin ® 58 ACZ# 58 KRAS status 58 cobicistat 58 pemetrexed 58 dasatinib 58 ceftriaxone 58 log# reduction 58 balsalazide 58 ARB telmisartan 58 chemoradiotherapy 58 temsirolimus 58 alkylating agent 58 serum HBV DNA 58 Tacrolimus 58 angiotensin receptor blocker ARB 58 PSA nadir 58 dexamethasone Decadron 58 p = #.# [003] 58 otamixaban 58 Dasatinib 58 chlorthalidone 58 iniparib 58 lymphocyte count 58 TMP SMX 58 Protelos 58 Revlimid lenalidomide 58 #mg BID [001] 58 DMARD 58 dose cohort 58 ALVESCO 58 MoxDuo IR 58 Androgel R 58 pyridostigmine 58 infliximab 58 FOLFOX 58 leuprorelin 58 lumbar spine BMD 58 cytotoxic chemotherapy 58 pegylated interferon 58 virologic responses 58 HBsAg 58 NPH insulin 58 ziprasidone 58 FOLPI 58 virologic suppression 58 Pegasys ® 58 doxazosin 58 rHuPH# 58 Pegylated Liposomal Doxorubicin 58 evaluable subjects 58 Pegintron 58 mg TID 58 Visipaque 58 NOXAFIL 58 zalutumumab 58 YERVOY 58 rhEPO 58 rhTSH 58 biphasic insulin aspart 58 nucleoside analogs 58 bronchodilation 58 Neupogen ® 58 tolterodine ER 58 glucose lowering 58 recurrent GBM 58 pegfilgrastim 58 inotropic 58 H2RAs 58 Tipranavir 58 5 Fluorouracil 58 Carvedilol 58 paliperidone ER 58 3mg/kg 58 GnRH agonists 58 #mg/day [001] 58 subcutaneous insulin 58 AEGR 58 entecavir 58 tamsulosin 58 relapsed ovarian cancer 58 nucleoside analogues 58 3TC lamivudine Epivir 58 abiraterone acetate 58 insulin glargine 58 MICARDIS ® 58 chemoradiation therapy 58 ertapenem 58 VAPRISOL 58 lopinavir 58 alpha blocker 58 docetaxel 58 Temozolomide 58 NNRTIs 58 aflibercept 58 elvitegravir 58 FOLFIRI alone 58 Telmisartan 58 administered subcutaneously 58 saline placebo 58 PEG Intron 58 bolus dose 58 achieved sustained virologic 57 lapatinib Tykerb 57 carvedilol 57 q8h 57 bolus injection 57 solifenacin 57 peg IFN 57 mg dose 57 ciclesonide 57 #:# randomization 57 paclitaxel carboplatin 57 rimonabant #mg 57 tenecteplase 57 platelet reactivity 57 aprepitant 57 baseline LDH 57 microg 57 surrogate endpoint 57 postintervention 57 undetectable HBV DNA 57 serum phosphorus 57 abatacept 57 LHRH agonists 57 Daptomycin 57 Candesartan 57 Procoralan 57 GHRH 57 microbiological eradication 57 Betaferon ® 57 Virologic 57 fluvastatin 57 antimicrobial prophylaxis 57 Ritonavir 57 Raptiva r 57 fluticasone furoate 57 β blocker 57 thiazide diuretic 57 serum urate 57 olmesartan 57 co trimoxazole 57 intravenous bisphosphonates 57 nab paclitaxel 57 Moxifloxacin 57 standard chemotherapy regimen 57 antihypertensive therapy 57 oral antidiabetic 57 IOP lowering 57 QTcF 57 rFVIIa 57 antiviral efficacy 57 Viread Emtriva 57 teriflunomide 57 busulfan 57 4mg/kg 57 Neoadjuvant 57 sipuleucel T 57 peg interferon 57 corticosteroid therapy 57 antiangiogenic therapy 57 alfa 2b 57 doripenem 57 ATACAND 57 sotalol 57 NeoRecormon 57 interferon alfa 2b 57 capecitabine Xeloda 57 Paraplatin ® 57 imatinib therapy 57 seropositive patients 57 Bortezomib 57 protease inhibitors PIs 57 gefitinib 57 Cloretazine 57 trastuzumab 57 olmesartan medoxomil 57 lymphadenectomy 57 ARIMIDEX 57 INC# 57 anti Xa 57 zonisamide SR 57 FOR FURTHER INFORMATION ABOUT 57 valsartan 57 alteplase 57 erlotinib 57 definite stent thrombosis 57 ribavirin therapy 57 hypotensive 57 rilonacept 57 timepoints 57 IV bolus 57 Navelbine 57 ZACTIMA 57 bosutinib 57 COMBIVIR 57 TAXOTERE R 57 bevacizumab Avastin ® 57 HBeAg positive 57 trimethoprim sulfamethoxazole 57 Nilotinib 57 eribulin mesylate 57 PegIntron 57 refractory AML 57 nephrotoxicity 57 Celsentri Selzentry 57 antihypertensive medications 57 trabedersen 57 dacarbazine chemotherapy 57 cytarabine daunorubicin 57 potent antiretroviral therapy 57 Camptosar ® 57 neoadjuvant treatment 57 mCi kg 57 ketorolac 57 GW# [003] 57 enalapril 57 median PFS 57 Median PFS 57 fulvestrant 57 Degarelix 57 low dose Iluvien 57 CRp 57 bezafibrate 57 Saquinavir 57 achieved statistical significance 57 TORISEL 57 GnRH agonist 57 methotrexate monotherapy 57 tapentadol ER 57 nevirapine Viramune 57 external beam radiotherapy 57 androgen suppression 57 discontinuations due 57 L PPDS 57 #mg QD [002] 57 intravesical 57 angiographic outcomes 57 postmenopausal osteoporotic women 57 immunomodulatory 57 ganciclovir 57 atazanavir 57 log# copies mL 57 zoledronic acid 57 plus gemcitabine 57 anastrozole 57 serum urate levels 57 Celecoxib 57 dose ritonavir 57 lacosamide 57 Viread Emtriva Sustiva 57 Taxotere chemotherapy 57 Imprime PGG 57 NEVO ™ 57 tolvaptan 57 postoperative chemotherapy 57 Vectibix monotherapy 57 recurrent glioblastoma multiforme 57 CAELYX 57 Vfend 57 preoperative chemotherapy 57 KRAS mutant tumors 57 CLL SLL 57 EBRT 57 imatinib Gleevec 57 chloride secretion 57 Amrubicin 57 vorinostat 57 Cyclosporine 57 simvastatin ezetimibe 57 Proleukin 57 binary restenosis 57 imiquimod cream 56 cediranib 56 taxotere 56 oxaliplatin Eloxatin 56 fluoropyrimidine 56 CR CRu 56 p = ns 56 Cypher Stent 56 peginterferon alpha 2a 56 cyclophosphamide Cytoxan 56 rituximab Rituxan 56 Hycamtin 56 nucleoside reverse transcriptase inhibitor 56 insulin glulisine 56 zidovudine AZT 56 serum HCV RNA 56 dacetuzumab 56 thromboembolic events 56 radiolabeled monoclonal antibody 56 BARACLUDE ® 56 IFN alpha 56 platinum refractory 56 metastatic CRC 56 Gliadel Wafer 56 biologic DMARD 56 Free Survival PFS 56 EGFRIs 56 HBeAg positive patients 56 efavirenz Sustiva 56 mcg kg 56 abacavir Ziagen 56 docetaxel Taxotere ® 56 TNF inhibitors 56 Fludarabine 56 adriamycin 56 titrated glipizide 56 plus ribavirin 56 antiretroviral naive 56 somatostatin analogs 56 Omacetaxine mepesuccinate 56 prasugrel Effient 56 BCG refractory 56 Peginterferon Alfa 2a 56 xenograft models 56 heavily pretreated 56 achieved ACR# 56 severe neutropenia 56 metastatic RCC 56 Retreatment 56 tenofovir Viread 56 undetectable viral load 56 fluconazole 56 gefitinib Iressa 56 ACE inhibitor ramipril 56 monotherapy 56 Gleevec resistant 56 daily subcutaneous injections 56 q#h 56 erythropoietic 56 Sustiva efavirenz 56 antiemetic 56 gp# vaccine 56 LANTUS R 56 Traficet EN 56 #mg/day [002] 56 PEG Interferon alfa 56 methotrexate therapy 56 anti TNF 56 immunomodulatory therapy 56 apremilast 56 VELCADE melphalan 56 ropivacaine 56 vidofludimus 56 #mg dose [001] 56 maximal dose 56 posttreatment 56 Emselex 56 lopinavir ritonavir Kaletra 56 GP IIb IIIa inhibitors 56 AZOR 56 sorafenib Nexavar 56 RE LY ® 56 neurologic progression 56 dutasteride 56 zidovudine lamivudine 56 prucalopride 56 MAGE A3 ASCI 56 gemcitabine 56 Sitagliptin 56 telaprevir dosed 56 adefovir dipivoxil 56 galiximab 56 EGFR antibodies 56 cisplatin gemcitabine 56 Combination therapy 56 mTOR inhibitors 56 liposomal formulation 56 INFERGEN 56 taxane chemotherapy 56 MYCAMINE 56 intravenous cyclophosphamide 56 lipid lowering agents 56 Aptivus 56 antitumor effect 56 valopicitabine 56 HAART regimen 56 amlodipine 56 Xelox 56 MoxDuo TM IR 56 Zyclara 56 intravenous dosing 56 erlotinib Tarceva ® 56 VIDAZA 56 Roche Xeloda 56 therapeutic regimens 56 palonosetron 56 LT NS# 56 Peginterferon 56 neoadjuvant therapy 56 INVIRASE 56 Tamibarotene 56 PREZISTA 56 anagrelide 56 virological response 56 achieved CCyR 56 levetiracetam 56 ASCT 56 Natalizumab 56 treat NNT 56 seroprotection 56 nucleoside reverse transcriptase inhibitors 56 ELOXATIN 56 Docetaxel 56 Delcath PHP System 56 immunosuppressive agents 56 Engerix B 56 STN stimulation 56 deferoxamine 56 plus MTX 56 standard chemotherapy regimens 56 capecitabine 56 rapid virologic response 56 betamethasone dipropionate 56 dose clopidogrel 56 ivabradine 56 favorable pharmacokinetic profile 56 quinolone 56 pegylated liposomal doxorubicin PLD 56 nucleoside analogue 56 ß blockers 56 pertuzumab 56 ACR# response 56 progression TTP 56 dimeglumine 56 sitagliptin 56 Anti TNF 56 Ramipril 56 incontinence episodes 56 RLAI 56 #.#mg/dL 56 crizotinib PF # 56 oral levofloxacin 56 tenofovir DF 56 solithromycin 56 intratumoral 56 carbidopa levodopa 56 5 HT3 receptor 56 TroVax ® 56 ritonavir boosted protease inhibitor 56 Eloxatin R 56 subcutaneously injected 56 rosuvastatin #mg 56 neoadjuvant 56 lamivudine monotherapy 56 G CSF 56 mcg albinterferon alfa 2b 56 patients evaluable 56 sorafenib Nexavar ® 56 ABVD 56 tiotropium 56 cetuximab Erbitux ® 56 cytostatic 56 anemia hemoglobin 56 infusional 56 allogeneic SCT 56 CCyR 56 CIMZIA TM certolizumab pegol 56 YONDELIS 56 antibody titres 56 antiandrogens 56 EndoTAG TM -1 56 valacyclovir 56 Prograf ® 56 COPEGUS 56 cefuroxime 56 CONCERTA 56 immunosuppressives 56 bevacizumab Avastin 56 Pazopanib 56 Lamivudine 56 iclaprim 56 saquinavir ritonavir 56 pegylated IFN 56 TEMODAL 56 Platinol ® cisplatin 56 Interferon alpha 56 lapatinib 56 Exforge HCT 56 tapentadol IR 56 bleomycin 56 VFEND 56 achieving PASI 55 paclitaxel eluting stents 55 irinotecan chemotherapy 55 clopidogrel Plavix 55 aldosterone antagonists 55 ximelagatran 55 nanomolar 55 oxcarbazepine 55 PSMA ADC 55 anti CD3 55 NovoTTF 55 taribavirin 55 triple nucleoside 55 carboplatin 55 T2 lesions 55 Melphalan 55 Sorafenib 55 concomitant medications 55 PROMACTA 55 Taxotere R 55 Tekamlo 55 stent binary restenosis 55 esomeprazole 55 herpetic keratitis 55 Lantus R 55 corrected QT interval 55 d4T 55 RAPAFLO R 55 EOquin 55 COPAXONE 55 pegylated interferon ribavirin 55 ISEL 55 μg ml 55 serum creatinine levels 55 thrombolytics 55 undetectable viral 55 Roche Pegasys 55 Increlex R 55 latanoprost 55 bortezomib Velcade 55 3TC 55 Isentress raltegravir 55 ug kg 55 Mycophenolate Mofetil 55 vivo potency 55 Rituxan MabThera 55 plus methotrexate 55 prior relapsers 55 antibody titers 55 proton pump inhibitor PPI 55 BMS # 55 lumiliximab 55 Dacogen decitabine 55 antiviral potency 55 statistically significant p = 55 captopril 55 FOLFOX6 55 #.#/#.# mmHg [001] 55 AMN# [001] 55 μmol L 55 rituximab 55 saquinavir 55 gemcitabine chemotherapy 55 Platinol 55 VNP#M 55 tamoxifen Nolvadex ® 55 gastric pH 55 NATRECOR ® 55 rapid virological response 55 Interferon beta 1a 55 paclitaxel Taxol ® 55 Omiganan 55 Torisel 55 bivalirudin 55 granisetron 55 serum phosphate levels 55 Pegylated interferon 55 TAXUS Stent 55 fluticasone 55 nucleoside analog 55 complete cytogenetic 55 INTEGRILIN 55 rHuEPO 55 moxifloxacin 55 partial remissions 55 detemir 55 LEXIVA 55 evaluating tivozanib 55 intermittent dosing 55 nucleotide analogue 55 linezolid 55 SPRYCEL ® 55 metastatic malignant melanoma 55 NRTI resistance 55 octreotide 55 alicaforsen enema 55 relapsing multiple sclerosis 55 BARACLUDE r 55 ketoconazole 55 Noxafil 55 % CI #.#-#.# [003] 55 amrubicin 55 RNA copies mL 55 tolterodine 55 nodular partial response 55 epirubicin cyclophosphamide 55 ALT flares 55 alefacept 55 lispro alone 55 mg RDEA# 55 trandolapril 55 concurrent chemoradiation 55 hydroxychloroquine 55 resected pancreatic cancer 55 VIAject ™ 55 hemagglutination inhibition 55 periprocedural 55 P = .# 55 receiving ISENTRESS 55 AmBisome 55 ritonavir Norvir 55 INVANZ 55 lipid lowering therapies 55 liposomal amphotericin B 55 Lopinavir 55 recurrent VTE 55 lanthanum carbonate 55 direct thrombin inhibitors 55 μg mL 55 HAQ DI 55 placebo 55 MabCampath 55 RAPAFLO 55 glufosfamide 55 Panzem R NCD 55 Exenatide Byetta 55 Tarceva TM 55 ticagrelor 55 mg simvastatin 55 ICD therapy 55 neutralizing antibody 55 REYATAZ ritonavir